Introduction. Heart failure (HF) is a clinical syndrome that affects more than 64 million people worldwide. It is a major reason for hospitalizations and adverse outcomes. Despite the development of new diagnostic tools for HF and its improved treatment, it remains a significant health and social problem. Its early diagnosis is of cardinal importance for reducing hospitalizations, improving prognosis, successful treatment, and prevention of future complications. Nowadays, there is an increasing interest on HF biomarkers. The use of appropriate biomarkers would allow accurate risk stratification for the purpose of early detection of HF and implementation of timely therapy. A growing number of studies on HF biomarkers reveal microRNAs (miR- NAs) as important regulators, providing insight into the molecular mechanisms underlying maladaptive ventricular remodeling and HF progression. Current investigations highlight the role of miRNAs as promis- ing non-invasive indicators for early diagnosis, prognosis, and HF severity. This review presents a recent approach to the general characteristics of miRNAs. Their potential implication as HF diagnostic and prognostic indicators is also discussed.
Keywords: microRNAs, biomarker, heart failure.
Address for correspondence:
Asparuh NIKOLOV
Address: Department of Preclinical and Clinical Sciences, Faculty of Pharmacy, Medical University-Pleven,1, St. Kliment Ohridski Str., 5800 Pleven, Bulgaria
Email: a_nicoloff@yahoo.com; Phone +359 887100672